The most pressing health challenges—whether in gastroenterology, immunology, or neuroscience—demand interdisciplinary collaboration. When researchers from different fields come together, they bring unique perspectives that can unlock new discoveries and accelerate progress.
This year, the GIN Discovery Program is offering two distinct funding opportunities for researchers and experts from other disciplines to partner with us:
🔹 Super Pitch ($50,000): Funding for an innovative, interdisciplinary project advancing gut-immune-brain axis research. This opportunity is open to researchers across disciplines, encouraging fresh ideas and novel collaborations.
🔹 GIN & MIME Co-Funding ($25,000): In partnership with the Monash Institute of Medical Engineering (MIME), this funding is dedicated to a technology-driven, healthcare-focused project that addresses an unmet clinical need related to the gut-immune-brain axis. This initiative encourages collaboration between clinicians, engineers, IT specialists, and researchers to translate scientific discoveries into real-world healthcare solutions.
Both funding opportunities are designed to catalyze new collaborations and push the boundaries of gut-immune-brain axis research. Whether you’re working on fundamental science or developing next-generation healthcare solutions, we invite you to partner with us and help shape the future of health.
WHY THE GUT-IMMUNE-BRAIN AXIS?
Medical research has long been structured around individual organs and systems, yet many health conditions arise from complex interactions across multiple biological domains. To drive more effective treatments, we must move beyond isolated investigations and embrace a systems-based approach.
The GIN Discovery Program is leading this shift by focusing on the gut-immune-brain axis, a critical network linking the gastrointestinal, immune, and nervous systems. Disruptions in this axis are associated with a wide range of conditions, from digestive disorders and autoimmune diseases to neurological and mental health challenges.
Through our Seed Funding Program, we are supporting research that bridges disciplines to uncover new insights into this interconnected system. By funding innovative projects that integrate gastroenterology, immunology, and neuroscience, we aim to advance knowledge, improve treatments, and ultimately enhance patient outcomes.